Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Acquisitions (Tables)

Acquisitions (Tables)

9 Months Ended

Sep. 30, 2023

Summary of Preliminary Allocation of Purchase Price

The following table summarizes the preliminary allocation of the purchase price over the estimated fair value of the assets acquired and liabilities assumed in the acquisition of Physio-Assist:


Cash	$	2,617
Accounts receivable		184
Inventories		296
Other assets		325
Property and equipment		82
Operating lease right-of-use asset		306
Intangible assets		34,100
Goodwill		9,991
Total assets acquired	$	47,901

Accounts payable and accrued expenses	$	1,108
Bank loans		2,158
Other current liabilities		419
Operating lease liability - noncurrent		263
Deferred tax liability - noncurrent		8,525
Total liabilities assumed		12,473
Total identifiable net assets	$	35,428

Cash consideration	$	32,250
Fair value of contingent earnout consideration		3,178
Total purchase price	$	35,428

Summary of Unaudited Pro Forma Information

The following unaudited pro forma information for the three and nine months ended September 30, 2023 and the three and nine months ended September 30, 2022 presents the revenues and operating income assuming the acquisition of Physio-Assist had occurred as of January 1, 2022.


	Three months ended						Nine months ended
	September 30,						September 30,
	2023			2022			2023			2022
Total revenue	$	84,680		$	105,793		$	242,060		$	290,587
Net loss	$	(45,321	)	$	(10,811	)	$	(77,266	)	$	(30,002	)